Oncopeptides Total Shares Rise to 445,287,003 After Directed Issue
Bitget2026/10/30 07:34- Oncopeptides’ total issued shares reached 445,287,003 as of October 30, 2026.
- The total comprises 431,357,758 ordinary shares and 13,929,245 class C shares.
- Voting rights totaled 432,750,682.5; share capital stood at SEK 49.48 million.
- The change follows a directed issue of 50,000,000 ordinary shares to Swedish and international institutional investors, announced October 13, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-IIFL Finance rallies to a two-month high, boosted by Blackstone deal
The “outlier” in the AI capital expenditure frenzy: Apple (AAPL.US) keeps spending flat, accounting for less than 5% of sales
Apple continues to stand out among major tech peers, largely avoiding the aggressive wave of capital expenditure associated with artificial intelligence (AI) infrastructure.
Youth Employment Declines for 48 Consecutive Months: Behind the Semiconductor Boom, Young South Koreans Are Being Left Behind by the Times
In South Korea, the unemployment rate in October fell to a three-year low of 2.5%. However, the number of employed people decreased by 50,000, youth employment has declined for 48 consecutive months, and domestic demand remains weak.
Crypto prices
More
